The EGF reduction was confirmed in rat PD models produced through cytotoxic lesion of the substantia nigra dopaminergic neurons, demonstrating that dopaminergic lesions reduce EGF content and limit EGFR activation [159]. This evidence concerns the gene EGFR and Parkinson disease.